{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/13/3311380/0/en/Rhythm-Pharmaceuticals-Presents-Positive-Interim-Six-month-Data-from-Phase-2-Trial-of-Setmelanotide-in-Patients-with-Prader-Willi-Syndrome-PWS-at-ENDO-2026.html", "message": "News view counter 798403 successfully enlarged"}